You searched for
We found 9 articles

GW572016 For Treatment Of Refractory Metastatic Breast Cancer

The purpose of this study is to determine the efficacy of an oral dual kinase inhibitor for the treatment of…

01 Jan 2013

Imatinib Mesylate in Treating Patients With Myelofibrosis

Imatinib mesylate may stop the growth of myelofibrosis by blocking certain enzymes necessary for cell growth. Official Title Phase II…

01 Jan 2013

Intrathecal Gemcitibine to Treat Neoplastic Meningitis

Gemcitabine is an investigational drug for treatment of neoplastic meningitis (cancer that has spread to the lining of the brain…

01 Jan 2013

Open label study of ONTAK (denileukin diftitox) in previously treated Cutaneous T-cell Lymphoma patients.

The purpose of this study is to provide an opportunity for patients who exhibit progressive disease while receiving placebo on…

01 Jan 2013

PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer

The goal of this clinical research study is to find the highest safe dose of PS-341 that can be given…

01 Jan 2013

Antibody Production in Immune Disorders

This study will evaluate immune function in people with a known or suspected immune disorder. It will determine participants’ immune…

01 Jan 2013

Diagnostic Study of Patients With Ewing’s Sarcoma

RATIONALE: Genetic testing may help predict how cancer will respond to treatment and allow doctors to plan more effective therapy.

01 Jan 2013

Irinotecan in Treating Children With Refractory Solid Tumors

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

01 Jan 2013

Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction

RATIONALE: Bortezomib may stop the growth of cancer cells by blocking the enzymes necessary for cancer cell growth. RATIONALE: Bortezomib…

01 Jan 2013